GleneaglesCRC is a premier full service CRO in the Asian-Australasian region, a joint venture of ParkwayHealth (Asia’s largest private healthcare network) and Mitsui Co. Ltd.

GleneaglesCRC has branch offices in eight countries: Singapore, China, Thailand, the Philippines, Indonesia, Australia, India and South Korea ( Taiwan and Japan by end 2010 ). GleneaglesCRC’s key strength is in providing local solution to companies for their global drug development across all therapeutic areas and in a diversified regulatory environment.

GleneaglesCRC has privileged access to all of ParkwayHealth’s doctors and hospitals ( including our investor’s hospital, in total 62 hospitals ) for example, Gleneagles Hospital, Mt Elizabeth Hospital, and Parkway East Hospital located in Singapore; Gleneagles Intan, in Kuala Lumpur; Gleneagles Medical Penang, Malaysia; and the entire Pantai Group of Hospitals in Malaysial the Apollo Gleneagles Hospital in Kolkatta, India and the Fortis group of hospitals in India; and the Gleneagles JPMC Brunei Cardiac Centre.

In addition to these sites, GleneaglesCRC has also worked with over 300 different hospital sites and 1000 investigators across 12 countries in Asia.